tiprankstipranks
EQL Pharma AB (SE:EQL)
:EQL
EQL
EQL Pharma AB
RESEARCH TOOLSreports

EQL Pharma AB (EQL) Price & Analysis

0 Followers

EQL Stock Chart & Stats

kr55.90
-kr0.60(-0.73%)
At close: 4:00 PM EST
kr55.90
-kr0.60(-0.73%)
Day’s Range― - ―
52-Week Rangekr21.35 - kr98.60
Previous CloseN/A
Volume16.99K
Average Volume (3M)33.07K
Market Cap
kr705.76M
Enterprise Valuekr2.32B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)54.3
Beta0.44
Next Earnings
Aug 07, 2026
EPS Estimate
-0.12
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.31
Shares Outstanding29,529,610
10 Day Avg. Volume21,678
30 Day Avg. Volume33,073
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.84
Revenue Forecast (FY)kr542.85M

EQL Pharma AB News

EQL Pharma Sets August 7 Date for Q1 2026/27 Interim Report Presentation
EQL Pharma Sets August 7 Date for Q1 2026/27 Interim Report Presentation
An update from EQL Pharma AB ( ($SE:EQL) ) is now available. EQL Pharma AB will release its...
1d ago
EQL Pharma’s Cystohipp Launch Opens New UTI Market in Germany
EQL Pharma’s Cystohipp Launch Opens New UTI Market in Germany
An announcement from EQL Pharma AB ( ($SE:EQL) ) is now available. EQL Pharma AB, a Swedish specialist...
27d ago
EQL Pharma Delivers Record Sales but Margin Hit Forces Sharper Focus and Slower Pipeline
EQL Pharma Delivers Record Sales but Margin Hit Forces Sharper Focus and Slower Pipeline
EQL Pharma AB ( ($SE:EQL) ) has shared an update. EQL Pharma reported record quarterly sales of SEK...
2M ago
7JK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
7JK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
EQL Pharma AB (7JK) is scheduled to report 4th quarter earnings on 05/08/2026. Regarding Q4 estimates, Wall Street...
2M ago
EQL Pharma Seeks New Supply Chain Chief to Bolster Niche Generics Strategy
EQL Pharma Seeks New Supply Chain Chief to Bolster Niche Generics Strategy
An update from EQL Pharma AB ( ($SE:EQL) ) is now available. EQL Pharma AB, a Lund-based generics...
3M ago
EQL Pharma Sets May 8 Presentation for Year-End 2025/26 Results
EQL Pharma Sets May 8 Presentation for Year-End 2025/26 Results
The latest update is out from EQL Pharma AB ( ($SE:EQL) ). EQL Pharma AB, a Lund-based specialist...
3M ago
EQL Pharma CEO Sells Small Stake to Cover Tax From Option Redemption
EQL Pharma CEO Sells Small Stake to Cover Tax From Option Redemption
An update from EQL Pharma AB ( ($SE:EQL) ) is now available. EQL Pharma AB, a Lund-headquartered generics...
4M ago
EQL Pharma Wins Italian Approval for Melatonin Drug Mellozzan
EQL Pharma Wins Italian Approval for Melatonin Drug Mellozzan
EQL Pharma AB ( ($SE:EQL) ) has issued an update. EQL Pharma’s key melatonin product Mellozzan has received...
4M ago
EQL Pharma Names Nomination Committee Ahead of 2026 AGM
EQL Pharma Names Nomination Committee Ahead of 2026 AGM
EQL Pharma AB ( ($SE:EQL) ) has provided an announcement. EQL Pharma AB has appointed its Nomination Committee...
5M ago
EQL Pharma Launches New Warrant-Based Incentive Programme for Key Employees
EQL Pharma Launches New Warrant-Based Incentive Programme for Key Employees
EQL Pharma AB ( ($SE:EQL) ) has provided an update. EQL Pharma AB’s extraordinary general meeting on 3...
5M ago

EQL FAQ

What was EQL Pharma AB’s price range in the past 12 months?
EQL Pharma AB lowest stock price was kr21.35 and its highest was kr98.60 in the past 12 months.
    What is EQL Pharma AB’s market cap?
    EQL Pharma AB’s market cap is kr705.76M.
      When is EQL Pharma AB’s upcoming earnings report date?
      EQL Pharma AB’s upcoming earnings report date is Aug 07, 2026 which is in 27 days.
        How were EQL Pharma AB’s earnings last quarter?
        EQL Pharma AB released its earnings results on May 08, 2026. The company reported kr0.31 earnings per share for the quarter, beating the consensus estimate of kr0.11 by kr0.2.
          Is EQL Pharma AB overvalued?
          According to Wall Street analysts EQL Pharma AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does EQL Pharma AB pay dividends?
            EQL Pharma AB does not currently pay dividends.
            What is EQL Pharma AB’s EPS estimate?
            EQL Pharma AB’s EPS estimate is -0.12.
              How many shares outstanding does EQL Pharma AB have?
              EQL Pharma AB has 29,529,610 shares outstanding.
                What happened to EQL Pharma AB’s price movement after its last earnings report?
                EQL Pharma AB reported an EPS of kr0.31 in its last earnings report, beating expectations of kr0.11. Following the earnings report the stock price went down -42.387%.
                  Which hedge fund is a major shareholder of EQL Pharma AB?
                  Currently, no hedge funds are holding shares in SE:EQL
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    EQL Pharma AB

                    EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports. It operates and markets products to Nordic countries of Sweden, Denmark, Finland and Norway.

                    EQL Pharma AB (EQL) Earnings & Revenues

                    Historic Earnings Reports

                    Technical Analysis

                    Overall Consensus
                    Sell
                    6Bullish
                    5Neutral
                    11Bearish
                    Bullish
                    Neutral
                    Bearish
                    Overall Consensus
                    6
                    5
                    11
                    Technical Analysis
                    2
                    5
                    3
                    Moving Averages
                    4
                    0
                    8
                    Technical Analysis >
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    HNSA
                    Hansa Biopharma AB
                    ―
                    ―
                    BOVNF
                    BioInvent International AB
                    ―
                    ―
                    CLLKF
                    BICO Group AB Class B
                    ―
                    ―
                    6Y4
                    Vicore Pharma Holding AB
                    ―
                    ―
                    6XP
                    Xspray Pharma AB
                    ―
                    ―
                    Compare SE:EQL Stocks >
                    Popular Stocks